DENALI THERAPEUTICS INC
DNLINASDAQ🏆 #1264 by market capEarnings Nov 4US Equity
$24.69▼ $0.31 (−1.24%)
Market closed · at close1h—
24h▼ 1.2%
7d▲ 1.0%
14d▲ 3.5%
30d▼ 6.8%
1y▲ 86.6%
🏦Market Cap
$3.92B
Small Cap
📈Revenue Growth (YoY)
—
📊Gross Margin
—
💵FCF Margin
—
⚖️P/S Ratio
1095.1x
Expensive
Otter Score
58
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-0.68
Expected
-0.51
miss
−32.50%
YoY +5.60%
Revenue
Actual
$3.60M
Expected
$2.15M
beat
+67.30%
Consensus estimates
Recent quarters
Q3 2026
-0.68
miss
Q2 2026
-0.69
beat
Q1 2026
-0.73
beat
Q4 2025
-0.74
beat